Clinical utility of serum leucine-rich alpha-2 glycoprotein for assessing disease activity and mucosal healing in ulcerative colitis across different treatment settings: a prospective observational cohort study
Clinical utility of serum leucine-rich alpha-2 glycoprotein for assessing disease activity and mucosal healing in ulcerative colitis across different treatment settings: a prospective observational cohort study
Yoriaki Komeda, Kohei Handa, George Tribonias, Shunsuke Omoto et al.
Journal
BMC Gastroenterology
Topics
Clusterin in disease pathology
article
Clinical utility of serum leucine-rich alpha-2 glycoprotein for assessing disease activity and mucosal healing in ulcerative colitis across different treatment settings: a prospective observational cohort study